A sweeping global study finds that India, China and the US will represent one -third of diabetes deaths and disabilities by 2050, unless urgent action is taken to reduce the increase in type 2 diabetes.
Study: Comparative diabetes mellitus tendencies in global, Chinese, US and Indian populations using GBD 2021 database. Credit Picture: Lightspring / Shutterstock
In a recent study published in the magazine Scientific reportsResearchers evaluated the trends in diabetes mellitus (DM) worldwide and in India, China and the United States (USA).
DM is a chronic disease characterized by the inability to adequately compose or respond to insulin, leading to unusually elevated blood glucose levels. Worldwide, about two million deaths occurred due to DM in 2019. In addition, the time increased blood glucose can cause microangiopathy and macrovascular disease, which can lead to complications such as blindness, heart disease, stroke and stroke.
DM and relative complications create a significant psychological and economic burden for families and the community. The prevalence of diabetes is rapidly increasing in low and medium -income countries, whose total health expenditure is more than 300 times lower than that of high income countries. These inequalities are particularly strong in areas with lower socio -economic growth (eg India) compared to high -income nations such as the US. This inequality underlines the need for comparative research on disorders.
Basic study elements
The present study evaluated trends in the DM load worldwide and in the three most densely populated countries, India, China and the US, from 1990 to 2021. A reflux model was used to identify turning points in trends.
In addition, the group calculates the annual rate of change in prevailing rates between turning points. In addition, they calculated the rates that have been standardized (ASRS) of the years of disabilities (DALYS) and deaths using age-of-fiber interaction. In addition, the burden of the disease has declined to various factors, such as epidemiological change, population size and age of the population.
An analysis of health inequality was carried out to examine the health disputes between populations and to investigate the relationship between factors such as age, gender, socio -economic status and their location and impact. Specifically, the analysis revealed that the burden of T2DM in high socio -demographic index (SDI) areas, such as the US, defied expectations, with higher than the planned Dalys than the National SDI. The weight of diabetes for 2022-50 was predicted using a Bayesian Age-Fiber Model (BAPC).
Findings
At the global level, DM had a significant impact in 2021, with significant fluctuations in morbidity and mortality between countries. India had the highest mortality weight, with more than 331,300 deaths, followed by China and the US, with 178,475 and 74,017 deaths, respectively. India’s mortality rate was more than double the US and almost 3.5 times higher than China when it was adapted to the age of the population (ASR). Consequently, Dalys’ distribution followed a similar trend, with India leading to 13.6 million Dalys, followed by China (11.71 million Dalys) and the US (5.04 million Dalys).
India also had the highest ASRS of deaths and Dalys per 100,000 people (31.1 deaths and 1,102 Dalys), followed by the US with 12.64 deaths and 959 Dalys and China with 8.98 deaths and 585 Dalys. In 1990, T1DM and T2DM represented 5.9% and 94.1% of deaths and 9.4% and 90.6% of Dalys, respectively. However, in 2021, deaths and Dalys due to T2DM increased to 97.1% and 95.4% and those due to T1DM decreased to 2.9% and 4.6% respectively.
Similar trends were observed in the three countries. ASR of T1DM deaths showed a reduced trend worldwide, with the most important decline from 2003 to 2011. Similarly, the DALYS ASR due to T1DM showed a similar standard, reducing the highest between 2004 and 2012. In contrast, the worldwide ASR of T2DM deaths increased to 2003 and increased until 2003 and increased by ASR and T2DM DALYS increased.
In the US, T1DM DALYS increased paradoxically by 0.17% per year (non-significant) despite mortality rates (-0.39%), reflecting increasing complications. The T1DM load was higher in men than in females and younger populations, especially in the age group 40-44, while the weight of T2DM increased with age, culminating in the age group 65-69 and was slightly lower in females than males. The three countries followed global trends. There has been a significant increase in 919,068 deaths worldwide due to DM between 1990 and 2019, with population growth (53.6%) and aging (36.51%) being the main drivers. Epidemiological changes (eg increasing rates of obesity) represented the remaining 9.89% of deaths.
Future views
The BAPC model has proposed a progressive decline in the T1DM cargo worldwide in all three countries, with the ASRS of Dalys and Deaths predicting to decline steadily and gradually. China’s T1DM load is expected to continue to fall abruptly due to prolonged policy interventions. On the contrary, the global T2DM load is projected to continue to increase, with an increase in DALYS and deaths. By 2050, global deaths due to T1DM and T2DM were expected to be 51,837 (6.7% increase from 2021) and 3.67 million (128.6% increase), respectively. In the US, T2DM DALYS is expected to increase despite the decline in mortality, led by complications such as cardiovascular disease and kidney failure, which are associated with prolonged hyperglycaemia.
Conclusions
In short, the T1DM presented a declining trend in world deaths and dalys, while T2DM showed an increasing trend. India has experienced the highest deaths and Dalys, followed by China. India, China and the US have shared about one -third of the global diabetes burden, underlining the need for greater attention than world health institutions for these countries.
The growth and aging of the population were the main factors that led to the weight of diabetes. Specifically, forecasts suggest continuous weight gain by T2DM by 2050. The study emphasizes that customized strategies are critical: India requires urgent upgrades of healthcare infrastructure, China must maintain the successes of T1DM management and the US should be tackled. Overall, these results justify the need to increase the awareness of the public of diabetes, the treatment of socio -economic inequalities, the improvement of equality in the distribution of health care resources and the implementation of preventive measures, early examination and lifestyle interventions to reduce DM weight.
